Manish Kohli

University of Utah

Full Professor(heuristic)

Prostate Cancer Treatment and Research · Pulmonary and Respiratory Medicine

Compare more Pulmonary and Respiratory Medicine professors.

h-index49
i10-index116
Publications538
Citations17,461

Grants

6 total · 1 active

NIH #UH2CA307747

A multimodal liquid biopsy assay to quantify androgen receptor’s somatic alterations in metastatic castration-resistant prostate cancer.

Active
Amount
$200K–$300K
Period
2026-03-162028-02-29
PIs
2

Awarded at H. LEE MOFFITT CANCER CTR & RES INST

NIH #R01EB032725

Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens

Amount
$600K–$700K
Period
2022-08-152026-05-31
PIs
2

Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN

NIH #R01EB029805

Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer

Amount
$500K–$600K
Period
2020-07-152024-03-31
PIs
3

Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

6 total · 1 active

NIH #UH2CA307747

A multimodal liquid biopsy assay to quantify androgen receptor’s somatic alterations in metastatic castration-resistant prostate cancer.

Active
Amount
$200K–$300K
Period
2026-03-162028-02-29
PIs
2

Awarded at H. LEE MOFFITT CANCER CTR & RES INST

NIH #R01EB032725

Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens

Amount
$600K–$700K
Period
2022-08-152026-05-31
PIs
2

Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN

NIH #R01EB029805

Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer

Amount
$500K–$600K
Period
2020-07-152024-03-31
PIs
3

Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN

NIH #R01CA227699

Daily Quantification of Cancer-Associated Exosomal miRNA in Patient Blood by Photonic Crystal-Enhanced Quantum Dot Emission

Amount
$300K–$400K
Period
2018-03-192023-02-28
PIs
2

Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN

NIH #R01CA212097

Cell free nucleic acid-based biomarkers in advanced prostate cancer

Amount
$600K–$700K
Period
2017-08-012022-07-31
PIs
2

Awarded at MEDICAL COLLEGE OF WISCONSIN

NIH #R21CA133536

A Proteomics Approach for Identifying Predictive Factors to Androgen Deprivation

Amount
$200K–$300K
Period
2009-07-162011-06-30
PIs
1

Awarded at MAYO CLINIC ROCHESTER

Recent Public Signals

  1. New preprint: Dissecting Multi-Omics Data for Cancer Survival Risk Prediction Using Variational Autoencoders: Current Trends, Challenges, and Opportunities2026-06-03
  2. New paper: HSD86 FIRST-LINE SYSTEMIC TREATMENT PATTERNS IN METASTATIC UROTHELIAL CARCINOMA IN US COMMUNITY ONCOLOGY PRACTICES (Value in Health)2026-06-01
  3. New NIH award: A multimodal liquid biopsy assay to quantify androgen receptor’s somatic alterations in metastatic castration-resistant prostate cancer.2026-03-16

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-01

Data may not be current

Find elsewhere

ORCID: 0000-0002-9735-6614

Professor Insights

Career Trajectory